Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Cognitive/Affective/Sleep Symptoms During High-dose Interleukin-2 Therapy

NCT02150369 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02150369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02150369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Cognitive/Affective/Sleep Symptoms During High-dose Interleukin-2 Therapy
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
February 16, 2015
Completion date
March 2, 2017
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-dose interleukin-2, metastatic melanoma, metastatic renal cell carcinoma